(VIANEWS) – ResMed (RMD), Coca Cola Femsa S.A.B. de C.V. (KOF), CB Financial Services (CBFV) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ResMed (RMD)
17.4% sales growth and 23.52% return on equity
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, ResMed has a trailing twelve months EPS of $5.48.
PE Ratio
ResMed has a trailing twelve months price to earnings ratio of 40.88. Meaning, the purchaser of the share is investing $40.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 3.76B for the twelve trailing months.
Sales Growth
ResMed’s sales growth is 20.6% for the present quarter and 17.4% for the next.
Moving Average
ResMed’s worth is higher than its 50-day moving average of $215.91 and above its 200-day moving average of $221.41.
2. Coca Cola Femsa S.A.B. de C.V. (KOF)
14.5% sales growth and 15.13% return on equity
Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages. The company offers sparkling beverages, including colas and flavored sparkling beverages; and waters and still beverages, such as juice drinks, coffee, teas, milk, value-added dairy products, sports drinks, energy drinks, and plant-based drinks. It provides a portfolio of products through retail outlets, such as wholesale supermarkets, discount stores, and convenience stores; retailers, such as restaurants and bars, as well as stadiums, auditoriums, and theaters; points-of-sale outlets; and home delivery and other locations. The company also distributes and sells Heineken beer products in its Brazilian territories. It operates in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. Coca-Cola FEMSA, S.A.B. de C.V. was founded in 1979 and is based in Mexico City, Mexico. Coca-Cola FEMSA, S.A.B. de C.V. is a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
Earnings Per Share
As for profitability, Coca Cola Femsa S.A.B. de C.V. has a trailing twelve months EPS of $4.99.
PE Ratio
Coca Cola Femsa S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 16.76. Meaning, the purchaser of the share is investing $16.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.13%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coca Cola Femsa S.A.B. de C.V. ‘s EBITDA is 1.68.
3. CB Financial Services (CBFV)
14% sales growth and 9.25% return on equity
CB Financial Services, Inc. operates as the bank holding company for Community Bank that provides various banking products and services for individuals and businesses in southwestern Pennsylvania, West Virginia, and Ohio. The company's primary deposit products include demand deposits, NOW accounts, money market accounts, and savings accounts, as well as time deposit products. Its loan products comprise residential real estate loans, such as one- to four-family mortgage loans, home equity installment loans, and home equity lines of credit; commercial real estate loans that are secured primarily by improved properties, such as retail facilities, office buildings, and other non-residential buildings; construction loans to individuals to finance the construction of residential dwellings, as well as for the construction of commercial properties, including hotels, apartment buildings, housing developments, and owner-occupied properties used for businesses; commercial and industrial loans, and lines of credit; consumer loans consisting of indirect auto loans, secured and unsecured loans, and lines of credit; and other loans. In addition, the company conducts insurance agency activities by offering property and casualty, commercial liability, surety, and other insurance products. It operates through its main office and 13 branch offices in Greene, Allegheny, Washington, Fayette, and Westmoreland counties in southwestern Pennsylvania; Marshall and Ohio counties in West Virginia; and Belmont County in Ohio, as well as one loan production offices in Allegheny County. The company was founded in 1901 and is headquartered in Carmichaels, Pennsylvania.
Earnings Per Share
As for profitability, CB Financial Services has a trailing twelve months EPS of $2.18.
PE Ratio
CB Financial Services has a trailing twelve months price to earnings ratio of 9.75. Meaning, the purchaser of the share is investing $9.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.25%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 17.2% and 3150%, respectively.
Volume
Today’s last reported volume for CB Financial Services is 1942 which is 41.83% below its average volume of 3339.
Yearly Top and Bottom Value
CB Financial Services’s stock is valued at $21.25 at 11:22 EST, way below its 52-week high of $24.98 and higher than its 52-week low of $20.49.
Revenue Growth
Year-on-year quarterly revenue growth declined by 24.5%, now sitting on 48.91M for the twelve trailing months.
4. Pacific Gas & Electric Co. (PCG)
11.8% sales growth and 8.13% return on equity
PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, engages in the sale and delivery of electricity and natural gas to customers in northern and central California, the United States. It generates electricity using nuclear, hydroelectric, fossil fuel-fired, fuel cell, and photovoltaic sources. The company owns and operates interconnected transmission lines; electric transmission substations, distribution lines, transmission switching substations, and distribution substations; and natural gas transmission, storage, and distribution system consisting of distribution pipelines, backbone and local transmission pipelines, and various storage facilities. It serves residential, commercial, industrial, and agricultural customers, as well as natural gas-fired electric generation facilities. The company was incorporated in 1905 and is based in Oakland, California.
Earnings Per Share
As for profitability, Pacific Gas & Electric Co. has a trailing twelve months EPS of $0.85.
PE Ratio
Pacific Gas & Electric Co. has a trailing twelve months price to earnings ratio of 19.92. Meaning, the purchaser of the share is investing $19.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.
5. Boston Scientific (BSX)
6% sales growth and 4.08% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $0.45.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 112.8. Meaning, the purchaser of the share is investing $112.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.08%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Boston Scientific’s EBITDA is 113.61.
Yearly Top and Bottom Value
Boston Scientific’s stock is valued at $50.76 at 11:22 EST, under its 52-week high of $53.21 and way higher than its 52-week low of $34.98.
Moving Average
Boston Scientific’s value is higher than its 50-day moving average of $48.62 and way above its 200-day moving average of $44.10.
Previous days news about Boston Scientific(BSX)
- According to Zacks on Tuesday, 25 April, "Both Boston Scientific and Edwards Lifesciences are set to report their quarterly results on Apr 26. "
- According to Zacks on Tuesday, 25 April, "Medical device companies like Boston Scientific (BSX Quick QuoteBSX – Free Report) , Thermo Fisher Scientific (TMO Quick QuoteTMO – Free Report) , Edwards Lifesciences (EW Quick QuoteEW – Free Report) and Align Technology (ALGN Quick QuoteALGN – Free Report) are likely to have been influenced by these abovementioned factors in the first quarter.", "Boston Scientific Corporation price-eps-surprise | Boston Scientific Corporation Quote"
- : Boston Scientific stock jumps into record territory after earnings beat, raised outlook. According to MarketWatch on Wednesday, 26 April, "Shares of Boston Scientific Corp. BSX jumped 2.8% into record territory in premarket trading Wednesday, after the medical technology company reported first-quarter results that beat expectations and raised its full-year outlook, citing a "robust pipeline" in 2023 and beyond. "
- Boston Scientific (bsx) Q1 earnings beat, 2023 view raised. According to Zacks on Wednesday, 26 April, "Boston Scientific Corporation price-consensus-eps-surprise-chart | Boston Scientific Corporation Quote"
- Boston Scientific (bsx) Q1 earnings: how key metrics compare to wall street estimates. According to Zacks on Wednesday, 26 April, "Here is how Boston Scientific performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
